Equities analysts at house broker finnCap reiterated their 15p target share price for Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) against the AIM-quoted life sciences company’s latest market price of 8.8p.
During a capital markets day held on Wednesday 30 November 2022, Poolbeg stressed its capabilities in the discovery and development of anti-viral drugs and anti-bacterial vaccines, as well as its proprietary patient datasets that aid these drug discovery programmes and wider business-development strategy.
Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF) told investors that the next phase of production testing has now begun at the State 16-2 LN-CC well in Utah.
Testing in 2021 previously saw peak initial production rates of around 1,100 barrels of oil equivalent per day, constrained due to surface limitations.
Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) said its co-founder Dr Maija Hollmén, has been appointed as chief scientific officer (CSO) of the company.
As CSO, Dr Hollmén will oversee preclinical and support clinical development for the clinical-stage biopharma company and her priority will be the further development of bexmarilimab, Faron's wholly-owned, novel precision cancer immunotherapy candidate.
Unigold Inc. (TSX-V:UGD, OTCQX:UGDIF) has said it intends to extend the expiry dates of a total of 16,629,167 share purchase warrants by six months to June 23, 2023. The warrants were issued under a private placement that closed on June 23, 2020, and are currently set to expire on December 23, 2022. Each warrant entitles the holder thereof to acquire one common share of the company at a price of $0.30 per common share and all other terms of the warrants, including exercise price, will remain the same. A total of 150,650 warrants are held by parties who are considered to be “related parties” of the company. The warrant extension is subject to the approval of the Toronto Venture Exchange (TSXV).
OTC Markets Group Inc. (OTCQX:OTCM), the operator of regulated markets for 12,000 US and international securities, has announced that TraWell Co SPA, a multinational company operating in the Airport Retail market, has qualified to trade on the OTCQX Best Market and begins trading today under the symbol TRWAF. Trading on the OTCQX Market offers companies efficient, cost-effective access to the US capital markets. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the US. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. TraWell chairman and CEO Rudolph Gentile said: “TraWell Co. is proud to start trading on the OTCQX Market. The company generates 50% of its revenues in America and has seen growing interest by US investors. With a Net Result of 2 million dollars in first the half of 2022, and the launch of the new strategic plan on October 18, the company offers to investors a unique opportunity to capitalize on the growth of air travel and passenger services worldwide.”
Victory Square Technologies Inc (CSE:VST, OTCQX:VSQTF) portfolio company Hydreight Technologies Inc has received final approval for its qualifying transaction to list its shares on the TSX Venture Exchange. The company’s shares are now trading under the symbol 'NURS' effective at market open on December 1, 2022. "We couldn't be more thrilled to begin trading on the TSXV," Hydreight CEO Shane Madden said. "This is a major step for the growth of our company as we continue to provide business partners, service providers, medspas, facilities and vendor partners with interactive, accessible, mobile health and wellness services across the United States."
Outlook Therapeutics Inc (NASDAQ:OTLK) announced that CEO Russ Trenary will participate in a panel discussion titled, “Take A Look At What's In Store For Wet AMD & Related Diabetic Eye Diseases,” at the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference on Thursday, December 8, 2022 at 2:45 PM ET.
Jushi Holdings Inc (CSE:JUSH, OTCQX:JUSHF) announced that Jushi’s management will participate in the following upcoming conferences: The Wolfe Research Consumer Growth Conference is being held virtually from December 5-6, 2022. Trent Woloveck, Chief Commercial Director, is scheduled to participate in a MSO group panel discussion at 3:20 p.m. ET; and Cowen’s Fifth Annual Cannabis Conference is being held virtually from December 6-8, 2022. Jim Cacioppo, Chief Executive Officer, Chairman and Founder, is scheduled to participate in a MSO group panel discussion on Wednesday, December 7, 2022, at 1:20 p.m. ET.